4 ASX stocks smashed down by more than 7% today

S&P/ASX 300 Index closes flat, but these four slumped by more than 7%

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 300 (Index: (AXKO) (ASX: XKO) ended flat today, as early falls were mainly offset by gains in our big four banks and Macquarie Group Ltd (ASX: MQG). The investment bank gained 2.7% today, continuing its strong run.

But that didn't help these four, which plunged more than 7%…

Covata Ltd (ASX: CVT) slipped 12.2% to 18 cents. The Australian data security company, which is partly owned by TPG Telecom Limited (ASX: TPM), has developed a technology to protect data and files, rather than targeting network security. Covata has a number of US customers, including in the US government and military, and is attempting to break into the European market, as well as the financial market.

Mining services company NRW Holdings Limited (ASX: NWH) lost 8.7% to end at 31.5 cents, despite no news from the company. Shares have dropped 75% since January 2014 as the slowdown in the resources sector gathers steam. Unfortunately for NRW, there's no bright light at the end of the tunnel, with mining investment set to decrease markedly over the next few years.

Neuren Pharmaceuticals Ltd (ASX: NEU) fell 8.3% to 16.5 cents today but are still up more than 40% since January 2. The company has submitted applications to the US Food and Drug Administration (FDA) for orphan drug designation and Breakthrough Therapy for drug NNZ-2566, which is used to treat the rare Rett syndrome. That follows a successful Phase 2 clinical trial, which showed benefits from treatment with NNZ-2566. Neuren expects to find out the results of its applications in the first half of 2015.

Sandalwood plantation owner TFS Corporation Limited (ASX: TFC) dropped 7.3% to $1.465, as trading in the company's shares continues to be a volatile ride. In the past six months, shares have hit a high of $2.24 and dropped as low as $1.17. That's despite the company announcing its sandalwood oil acne products have debuted in US stores earlier this month and that it's on track to make a $70 million profit in the 2015 financial year – placing the company on a P/E ratio of just 7x.

Motley Fool writer/analyst Mike King owns shares in TFS Corporation and TPG Telecom. You can follow Mike on Twitter @TMFKinga

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »